Brief: Microbot Medical Accelerates Patient Enrollment Of Human Clinical Trial for LIBERTY
30/09/2024 13:48
Sept 30 (Reuters) - Microbot Medical Inc MBOT.O :
* MICROBOT MEDICAL ACCELERATES PATIENT ENROLLMENT OF ITS
PIVOTAL
HUMAN CLINICAL TRIAL; EXPECTS TO COMPLETE THE TRIAL EARLIER THAN
ANTICIPATED AS 80% OF PATIENTS HAVE COMPLETED FOLLOW UP
* MICROBOT MEDICAL INC - 80% OF PATIENTS COMPLETED
FOLLOW-UP,
TRIAL TO FINISH AHEAD OF SCHEDULE
* MICROBOT MEDICAL INC - ON TRACK FOR FDA 510(K) SUBMISSION
BY END
OF 2024
Source text for Eikon: urn:newsml:reuters.com:*:nGNXm0Gk7
Further company coverage: MBOT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Microbot Medical
See all newsBrief: Microbot Medical® Enters Into An Agreement To Expand Access For America’S Veteran And Military Patient Populations
Microbot Medical rises as U.S. federal supply deal expands reach of robotic surgical device
Brief: Microbot Medical Recorded Revenue During Its Quarter Ended March 31, Benefiting From Limited Market Release Of Liberty System
Brief: Microbot Medical®’S Liberty® Endovascular Robotic System Is Now Adopted By Multiple Accounts Across Key Territories Including Two Access-Pvi Pivotal Clinical Trial Sites
Brief: Microbot Medical Continues Its 2025 Momentum Announces Key 2026 Milestones